Autoimmunity as a result of escape from RNA surveillance

Journal of Immunology

Volumn 177, Issue 3, 2006, Pages 1698-1707

  Bachmann, Michael P ^a   Bartsch, Holger ^a   Gross, Joanne K ^b   Maier, Shannon M ^b,c   Gross, Timothy F ^b   Workman, Jennifer L ^b   James, Judith A ^b,c   Farris, A Darise ^b,c   Jung, Bettina ^a   Franke, Claudia ^a   Conrad, Karsten ^a   Schmitz, Marc ^a   Büttner, Cordula ^a   Buyon, Jill P ^d   Semsei, Imre ^e   Harley, John B ^b,c,f   Rieber, E Peter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LA ANTIGEN; MESSENGER RNA; MUTANT PROTEIN; RNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LUPUS LIKE SYNDROME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RIBOSOMAL FRAMESHIFTING; RNA TRANSLATION; STOP CODON; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE;

EID: 33746214816     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.3.1698     Document Type: Article

References (39)

1. Fasken, M. B., and H. A. Corbett. 2005. Process or perish: quality control in mRNA biogenesis. Nat. Struct. Biol. 12: 482-489.
2. Weischenfeldt, J., J. Lykke-Andersen, and B. Porse. 2005. Messenger RNA surveillance: neutralizing natural nonsense. Curr. Biol. 15: R559-R562.
3. Schell, T., T. Kocher, M. Wilm, B. Seraphin, A. E. Kulozik, and M. W. Hentze. 2003. Complexes between the nonsense-mediated mRNA decay pathway factor upf1 (up-frameshift protein 1) and essential nonsense-mediated mRNA decay factors in HeLa cells. Biochem. J. 373: 775-783.
4. Culbertson, M. R. 1999. RNA surveillance: unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet. 15: 74-80.
5. Hentze, M. W., and A. E. Kulozik. 1999. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96: 307-304.
6. Medghalchi, S. M., P. A. Frischmeyer, J. T. Mendell, A. G. Kelly, A. M. Lawler, and H. C. Dietz. 2001. Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum. Mol. Genet. 10: 99-105.
7. Tröster, H., T. Metzger, I. Semsei, M. Schwemmle, A. Winterpacht, M. Zabel, and M. Bachmann. 1994. One gene, two transcripts: isolation of an alternative transcript encoding for the autoantigen La/SS-B from a cDNA library of a patient with primary Sjögren's syndrome. J. Exp. Med. 180: 2059-2067.
8. Grölz, D., J. Laubinger, F. Wilmer, H. Tröster, and M. Bachmann. 1997. Transfection analysis of expression of mRNA isoforms encoding the nuclear autoantigen La/SS-B. J. Biol. Chem. 18: 12076-12082.
9. Grölz, D., H. Bartsch, H. Tröster, and M. Bachmann. 1997. The nuclear autoantigen La/SS-B: mapping and sequencing of the gene and the three retropseudo-genes. Gene 191: 23-29.
10. Bachmann, M., H. Tröster, H. Bartsch, and D. Grölz. 1996. A frame shift mutation in a hot spot of the nuclear autoantigen La/SSB. J. Autoimmun. 9: 747-756.
11. Simons, F. H., F. J. Broers, W. J. Van Venrooij, and G. J. Pruijn. 1996. Characterization of cis-acting signals for nuclear import and retention of the La (SS-B) autoantigen. Exp. Cell Res. 224: 224-236.
12. Maraia, R. J., D. J. Kenan, and J. D. Keene. 1994. Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol. Cell. Biol. 14: 2147-2158.
13. Maraia, R. J. 1996. Transcription termination factor La is also an initiation factor for RNA polymerase III. Proc. Natl. Acad. Sci. USA 93: 3383-3387.
14. Fan, H., A. L. Sakulich, J. L. Goodier, X. Zhang, J. Qin, and R. J. Maraia. 1997. Phosphorylation of the human La antigen on serine 366 can regulate recycling of RNA polymerase III transcription complexes. Cell 88: 707-715.
15. Yoo, C. J., and S. L. Wolin. 1997. The yeast La protein is required for the 3′endonucleolytic cleavage that matures tRNA precursors. Cell 89: 393-402.
16. Gottlieb, E., and J. A. Steitz. 1989. The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro. EMBO J. 8: 841-850.
17. Gottlieb, E., and J. A. Steitz. 1989. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J. 8: 851-861.
18. McLaren, R. S., N. Caruccio, and J. Ross. 1997. Human La protein: a stabilizer of histone mRNA. Mol. Cell. Biol. 17: 3028-304.
19. Meerovitch, K., J. Pelletier, and N. Sonenberg. 1989. A cellular protein that binds to the 5′-non-coding region of poliovirus RNA: implications for internal translation initiation. Genes Dev. 3: 1026-1034.
20. Meerovitch, K., Y. V. Svitkin, H. S. Lee, F. Lejbkowicz, D. J. Kenan, E. K. Chan, V. I. Agol, J. D. Keene, and N. Sonenberg. 1993. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67: 3798-3807.
21. Svitkin, Y. V., K. Meerovitch, H. S. Lee, J. N. Dholakia, D. J. Kenan, V. I. Agol, and N. Sonenberg. 1994. Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J. Virol. 68: 1544-1550.
22. Svitkin, Y. V., A. Pause, and N. Sonenberg. 1994. La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 68: 7001-7007.
23. Gutierrez-Escolano, L., and R. M. del Angel. 1996. Nuclear proteins bind to poliovirus 5′ untranslated region. Arch. Med. Res. 27: 413-419.
24. Ali, N., and A. Siddiqui. 1997. The La antigen binds 5′noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site mediated translation. Proc. Natl. Acad. Sci. USA 94: 2249-2254.
25. Pogue, G. P., J. Hofmann, R. Duncan, J. M. Best, J. Etherington, R. D. Sontheimer, and H. L. Nakhasi. 1996. Autoantigens interact with cis-acting elements of Rubella virus RNA. J. Virol. 70: 6269-6277.
26. De, B. P., S. Gupta, H. Zhao, J. A. Drazba, and A. K. Banerjee. 1996. Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and La protein with cis-acting RNAs of human parainfluenza virus type 3. J. Biol. Chem. 271: 24728-24735.
27. Park, Y. W., and M. G. Katze. 1995. Translational control by influenza virus. J. Biol. Chem. 270: 28433-28434.
28. s6k. EMBO J. 16: 3693-3704.
29. Pellizzoni, L., B. Cardinali, N. Lin-Marq, D. Mercanti, and P. Pierandrei-Amaldi. 1996. Xenopus laevis homologue of the La autoantigen binds the pyrimidine tract of the 5′ UTR of ribosomal protein mRNAs in vitro: implication of a protein factor in complex formation. J. Mol. Biol. 259: 904-904.
30. Perrotti, D., and B. Calabretta. 2004. Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene 23: 3222-324.
31. Holcik, M. 2003. Translational upregulation of the X-linked inhibitor of apoptosis. Ann. NY Acad. Sci. 1010: 249-258.
32. Trotta, R., T. Vignudelli, O. Candini, R. V. Intine, L. Pecorari, C. Guerzoni, G. Santilli, M. W. Byrom, S. Goldoni, L. P. Ford, et al. 2003. BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell 3: 145-144.
33. Buyon, J. P., R. Hiebert, J. Copel, J. Craft, D. Friedman, M. Katholi, L. A. Lee, T. T. Provost, M. Reichlin, L. Rider, et al. 1998. Autoimmune- associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 31: 1658-1666.
34. Bachmann, M., D. Grölz, H. Bartsch, R. R. Klein, and H. Tröster. 1997. Analysis of expression of an alternative La (SS-B) cDNA and localization of the encoded N- and C-terminal peptides. Biochim. Biophys. Acta 27: 53-63.
35. Lawson, B. R., R. Baccala, M. Croft, D. H. Kono, and A. N. Theofilopoulos. 2004. Deficiency of cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T-cells and inhibits spontaneous systemic autoimmunity. J. Exp. Med. 199: 547-557.
36. Keech, C. L., A. A. Farris, D. Beroukas, T. P. Gordon, and J. McCluskey. 2001. Cognate T cell help is sufficient to trigger anti-nuclear autoantibodies in naive mice. J. Immunol. 166: 5826-5835.
37. Sahin, U., Ö. Türeci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92: 11810-11813.
38. Winter, S. F., J. D. Minna, B. E. Johnson, T. Takahashi, A. F. Gazdar, and D. P. Carbone. 1992. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutations. Cancer Res. 52: 4168-4174.
39. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-394.